default author photo

Yuqi Gao

Shandong First Medical University

Qingdao

China

SCHOLARLY PAPERS

4

DOWNLOADS

121

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Novel Oxadiazole Analogs as Anticancer Agents: Design, Synthesis, In Vitro and In Vivo Biological Evaluation, and Computer Studies of Sphingosine Kinase Inhibitors

Number of pages: 40 Posted: 22 Sep 2025
Shandong First Medical University, Shandong First Medical University, Shandong University - Shandong Provincial Qianfoshan Hospital, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, University of Fukui and Shandong University
Downloads 50 (1,074,648)

Abstract:

Loading...

SphK inhibitors, S1P, virtual screening, structure-based drug design, structure activity relationship, anti-prostatic cancer

2.

Identification of a Novel and Potent Oxadiazole-Based Sphingosine Kinase 2 Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of Prostatic Cancer

Number of pages: 41 Posted: 16 Jul 2025
Shandong First Medical University, Shandong First Medical University, Shandong University - Shandong Provincial Qianfoshan Hospital, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, University of Fukui and Shandong University
Downloads 34 (1,290,922)

Abstract:

Loading...

SphKs inhibitors, S1P, virtual screening, structure-based drug design, structure-activity relationship, anti-prostatic cancer

3.

Design, Synthesis, and Biological Evaluation of Sphingosine Kinase 2 Inhibitors Derived from K145

Number of pages: 56 Posted: 09 Feb 2026
Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong University - Shandong Provincial Qianfoshan Hospital, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University and Shandong First Medical University
Downloads 19 (1,509,872)

Abstract:

Loading...

Sphingosine Kinase Inhibitors, K145, anticancer, Structure-activity relationship

4.

Identification of a Novel, Potent, and Orally Bioavailable Oxadiazole-Based Sphingosine Kinases Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of Prostatic Cancer

Number of pages: 58 Posted: 18 Dec 2024
Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, affiliation not provided to SSRN, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University, University of Fukui, Shandong First Medical University, Shandong First Medical University, Shandong First Medical University and Shandong First Medical University
Downloads 18 (1,491,251)
Citation 1

Abstract:

Loading...

Sphingosine kinase inhibitors, Computer-aided drug design, S1P, structure-activity relationship